Literature DB >> 18472371

A novel M163L mutation in connexin 26 causing cell death and associated with autosomal dominant hearing loss.

T D Matos1, H Caria, H Simões-Teixeira, T Aasen, O Dias, M Andrea, D P Kelsell, G Fialho.   

Abstract

Mutations in GJB2 gene (encoding connexin 26) are the most common cause of hereditary non-syndromic sensorineural hearing loss (NSSHL) in different populations. The majority of GJB2 mutations are recessive, but a few dominant mutations have been associated with hearing loss either isolated or associated with skin disease. We describe a novel dominant pathogenic GJB2 mutation, identified in a Portuguese family affected with bilateral mild/moderate high-frequency NSSHL. In vitro functional studies demonstrate that the mutant protein (p.M163L) has defective trafficking to the plasma membrane and is associated with increased cell death.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18472371     DOI: 10.1016/j.heares.2008.03.004

Source DB:  PubMed          Journal:  Hear Res        ISSN: 0378-5955            Impact factor:   3.208


  13 in total

Review 1.  Two Iranian families with a novel mutation in GJB2 causing autosomal dominant nonsyndromic hearing loss.

Authors:  Niloofar Bazazzadegan; Abraham M Sheffield; Masoomeh Sobhani; Kimia Kahrizi; Nicole C Meyer; Guy Van Camp; Nele Hilgert; Seyedeh Sedigheh Abedini; Farkhondeh Habibi; Ahmad Daneshi; Carla Nishimura; Matthew R Avenarius; Mohammad Farhadi; Richard J H Smith; Hossein Najmabadi
Journal:  Am J Med Genet A       Date:  2011-04-11       Impact factor: 2.802

2.  Understanding of the molecular evolution of deafness-associated pathogenic mutations of connexin 26.

Authors:  Xin-Huan Han; Yi Fan; Qin-Jun Wei; Guang-Qian Xing; Xin Cao
Journal:  Genetica       Date:  2014-12-02       Impact factor: 1.082

Review 3.  Do cell junction protein mutations cause an airway phenotype in mice or humans?

Authors:  Eugene H Chang; Alejandro A Pezzulo; Joseph Zabner
Journal:  Am J Respir Cell Mol Biol       Date:  2011-02-04       Impact factor: 6.914

4.  Intracellular cysteine 346 is essentially involved in regulating Panx1 channel activity.

Authors:  Stefanie Bunse; Matthias Schmidt; Nora Prochnow; Georg Zoidl; Rolf Dermietzel
Journal:  J Biol Chem       Date:  2010-09-09       Impact factor: 5.157

Review 5.  Diverse deafness mechanisms of connexin mutations revealed by studies using in vitro approaches and mouse models.

Authors:  Emilie Hoang Dinh; Shoeb Ahmad; Qing Chang; Wenxue Tang; Benjamin Stong; Xi Lin
Journal:  Brain Res       Date:  2009-02-20       Impact factor: 3.252

6.  EKV mutant connexin 31 associated cell death is mediated by ER stress.

Authors:  Daniel Tattersall; Claire A Scott; Colin Gray; Daniel Zicha; David P Kelsell
Journal:  Hum Mol Genet       Date:  2009-09-14       Impact factor: 6.150

7.  A novel missense mutation in the second extracellular domain of GJB2, p.Ser183Phe, causes a syndrome of focal palmoplantar keratoderma with deafness.

Authors:  Eugene A de Zwart-Storm; Michel van Geel; Pierre A F A van Neer; Peter M Steijlen; Patricia E Martin; Maurice A M van Steensel
Journal:  Am J Pathol       Date:  2008-09-11       Impact factor: 4.307

8.  Dominant connexin26 mutants associated with human hearing loss have trans-dominant effects on connexin30.

Authors:  Sabrina W Yum; Junxian Zhang; Steven S Scherer
Journal:  Neurobiol Dis       Date:  2010-01-21       Impact factor: 5.996

9.  Insights on the mechanisms of Ca(2+) regulation of connexin26 hemichannels revealed by human pathogenic mutations (D50N/Y).

Authors:  William Lopez; Jorge Gonzalez; Yu Liu; Andrew L Harris; Jorge E Contreras
Journal:  J Gen Physiol       Date:  2013-07       Impact factor: 4.086

Review 10.  Connexinopathies: a structural and functional glimpse.

Authors:  Isaac E García; Pavel Prado; Amaury Pupo; Oscar Jara; Diana Rojas-Gómez; Paula Mujica; Carolina Flores-Muñoz; Jorge González-Casanova; Carolina Soto-Riveros; Bernardo I Pinto; Mauricio A Retamal; Carlos González; Agustín D Martínez
Journal:  BMC Cell Biol       Date:  2016-05-24       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.